UCB SA (UNC BE) stock market data APIs
€205.0277
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
UCB SA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UNC.BE.
Prev. Close
205.0277
Open
205.0277
High
205.0277
Low
205.0277
52 wk Range
134.6088-210
Market Cap
18 821 M
Dividends (Yield)
0.0149
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UCB SA data using free add-ons & libraries
Get UCB SA Fundamental Data
UCB SA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UCB SA News
New
Europe Refractory Epilepsy Treatment Research Report 2025 | Market to More Than Double to Reach $2.82 Billion by 2035, Driven by CBD Growth, Uptake of Neuromodulation Therapies, Strong R&D Pipeline
Company Logo The Europe refractory epilepsy treatment market is anticipated to grow from $1.34 billion in 2024 to $2.82 billion by 2035, with a CAGR of 6.98% from 2025 to 2035. This shift towards per...
Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care
Survey insights reveal that despite many participants living with psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), which includes both non-radiographic axial spondyloarthritis (nr-axSpA) ...
A Fresh Look at UCB (ENXTBR:UCB) Valuation After Recent Share Price Momentum
If you have been following UCB (ENXTBR:UCB), the recent moves in its share price have probably caught your eye. After an extended period of subdued trading, investors are starting to wonder if somethi...
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies Data include an open-label extension study descr...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
